Behind The Knife: The Surgery Podcast27 Juli

Clinical Challenges in Breast Surgery: The Fundamentals of Cancer Immunotherapy

Immune checkpoint inhibitors have rapidly reshaped care for triple-negative breast cancer (TNBC)—but surgical teams increasingly encounter their downstream perioperative consequences. In this episode, we define immunotherapy through the lens of checkpoint biology, review the landmark evidence supporting pembrolizumab in metastatic PD‑L1–positive TNBC (KEYNOTE‑355) and curative-intent stage II–III TNBC (KEYNOTE‑522), and translate immune-related adverse events (irAEs) into practical periop recognition, triage, and timing decisions—especially for endocrine, pulmonary, hepatic, dermatologic, and GI toxicities.

Hosts:
- Rashmi Kumar, MD, PhD
Resident, University of Michigan General Surgery Residency Program
Twitter/X: @RashmiJKumar
- Melissa Pilewskie, MD
Attending Breast Surgical Oncologist, Co-Director of the Weiser Family Center for Breast Cancer, Michigan Medicine
Twitter/X: @MPilewskie
- Stephanie Downs-Canner, MD
Attending Breast Surgical Oncologist & Physician-Scientist, Memorial Sloan Kettering Cancer Center, Program Director of the Breast Surgical Oncology Fellowship Training Program
Twitter/X: @SDownsCanner

Learning Objectives:

Define immunotherapy and immune checkpoint inhibition in breast cancer
Summarize current clinical indications and pivotal evidence for pembrolizumab in TNBC
Equip perioperative clinicians to identify and manage immune-related adverse events (irAEs) or side effects of immunotherapy.

Rationale for Immunotherapy in Breast Cancer Review

Selecting Triple Negative Breast Cancer Patients for Immunotherapy: https://pubmed.ncbi.nlm.nih.gov/37714640/

Landmark Clinical Trials Discussed in this Episode

KEYNOTE-355: https://pubmed.ncbi.nlm.nih.gov/33232653/
KEYNOTE-522: https://pubmed.ncbi.nlm.nih.gov/33232642/
IMpassion130: https://pubmed.ncbi.nlm.nih.gov/30345906/
IMpassion131: https://pubmed.ncbi.nlm.nih.gov/33930478/

Assessment of Surgical Outcomes in patients receiving chemoimmunotherapy

Surgical outcomes after neoadjuvant chemoimmunotherapy in triple-negative breast cancer: https://pubmed.ncbi.nlm.nih.gov/38332314/

Immune Related Adverse Events and Management

Schneider BJ, et al. Management of immune-related adverse events: https://pubmed.ncbi.nlm.nih.gov/34724392/
Brahmer JR, et al. SITC clinical practice guideline: https://pubmed.ncbi.nlm.nih.gov/34177534/

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(500)

USA vs. UK: ASGBI Ep. 10 - The Nuanced Approach to Abdominal Wall Reconstruction

In this episode, we discuss all things abdominal wall reconstruction. What is this new developing field, just patching “holes” with meshes or something more? We delve into the impact of the robot in t...

17 Aug 38min

Surgical Endoscopy Series Ep. 5: Novel Endosurgical Techniques

In this surgical endoscopy episode, the BTK team introduces endoscopic surgical procedures that are perhaps less well known. They cover primary endoscopic treatments for gastroesophageal reflux, esoph...

13 Aug 41min

Journal Review in Minimally Invasive Surgery: Digital Surgery

Digital surgery has morphed from buzzword into ubiquitous high-impact technology. In this episode, the BTK MIS team steps into the rapidly evolving ecosystem of cameras, sensors, robotics, and softwar...

10 Aug 28min

Journal Review in Thoracic Surgery: Empowering IMGs in CT Surgery - the Time to Act is Now

Navigating the path to becoming a surgeon in the US as an International Medical Graduate (IMG) can definitely have its hurdles. In this episode we sit down with Professor of Surgery, Dr. Ourania Preve...

6 Aug 26min

Clinical Challenges in Burn Surgery: Have Some Skin (Substitutes) In the Game

Join our burn team as they dive into the complex world of skin substitutes in burn care, breaking down a practical four-axis framework to help clinicians navigate product selection, patient factors, a...

3 Aug 29min

Power, Partnerships, and the Reality of Global Surgery Collaboration

In this episode of the Behind the Knife Global Surgery Series, we take a closer look at the real-world complexity of global surgery partnerships between high-income institutions and partners in the Gl...

30 Juli 29min

Journal Review in Hernia Surgery: What is Bioresorbable Mesh and Is It Worth It?

Join our OHSY Hernia team to review the current landscape of bioresorbable meshes and a conversation considering “are they worth it?"Hosts: Dr. Maggie Bosley - @MBosleyMD Dr. Sean Orenstein - @Orenst...

23 Juli 28min